Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Søren Johan BrunSenior Advisor
Read more about Søren
Copenhagen, August 29, 2021 What can we learn from Swedish Investors about Life Science Investments? On Monday the 29th of August our non-executive partner Stefan Lundgren presented at Økonomiske Ugebrevs Life Science Conference. In his presentation, Stefan discussed his view on the dynamics and differences between the Swedish and Danish Life Science space, based on…
Copenhagen, January 1, 2022 To download the 2022 New Years Greeting in English, press here. Gemstone Capital New Year 2022 To download the 2022 New Years Greeting in Danish, press here. Gemstone Capital Nytår 2022
Copenhagen, January 1 2021 Gemstone Capital promotes Kristoffer Lippert to Associate Director and opens up for new career opportunities. We are happy to announce that as of January 1st, 2022, Kristoffer is promoted to Associate Director at Gemstone Capital. Kristoffer joined the Gemstone team in the fall of 2020 as Project Manager. From day one,…
December 2021: 4.6mDKK Pre-IPO funding for life-science company DK life-science company [name undisclosed] with unique platform technology closes a pre-IPO round, as a last step prior to an anticipated IPO in 2022. Gemstone acts as the Company’s financial advisor, and facilitated the process and transaction. June 2021: 10.2mDKK pre-IPO convertible loan for Brain+ Brain+ closes…
Copenhagen, December 2021 “Best Danish share, if we look at all shares in Denmark (and not just C25) is Freetrailer with a return of as much as 354% (!)” Freetrailer was Gemstone Capital’s IPO #5 (2018) Read more about the win here (in Danish).
Copenhagen, December 2021 Brain+ lands partnership with Roche for entry in Germany 2 years ahead of plan. “Brain+ has signed a partnership agreement with RoX Health (https://roxhealth.com/), a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.” Read more about the partnership HERE. Brain+…
Copenhagen, December 2021 “ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its capsid virus-like particle (cVLP) breast cancer vaccine candidate ES2B-C001 demonstrated strong tumor-growth inhibiting effect in a mice model, thus reaching an important pre-clinical milestone ahead of schedule.” Read more about the exciting news HERE. Expres2ion was Gemstone Capital’s first IPO…
Copenhagen, December 2021 “ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that the ABNCoV2 vaccine demonstrated a strong boosting effect in the clinical Phase II trial conducted by Bavarian Nordic. ” Read more about the exciting news HERE. Expres2ion was Gemstone Capital’s first IPO (2016)
Copenhagen, 16 November 2021 Managing Partner Søren Jonas Bruun in the studio [03:35:50] on the status on the First North market in Copenhagen and announcing Gemstone research comparing the Danish and Swedish markets.
Copenhagen, December 2021 “We are thrilled to be working together with world leading research organizations like Fraunhofer FEP and imec. Their expertise in this area is highly renown, and the fact that they are committed and enthusiastic about our project makes me very confident that we will achieve our goal,” says Clas Dyrholm, CEO of…